G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.75 HKD 0.21% Market Closed
Market Cap: 16.9B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Relative Value

The Relative Value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 6.39 HKD. Compared to the current market price of 4.75 HKD, Grand Pharmaceutical Group Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6.39 HKD
Undervaluation 26%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
61
Median 3Y
1.6
Median 5Y
1.9
Industry
2.5
Forward
1.4
vs History
74
vs Industry
38
Median 3Y
7.6
Median 5Y
8.5
Industry
21.8
Forward
8.5
vs History
79
vs Industry
42
Median 3Y
8.3
Median 5Y
8.9
Industry
16.1
vs History
11
vs Industry
19
Median 3Y
12.4
Median 5Y
15.5
Industry
23.8
vs History
73
vs Industry
60
Median 3Y
1.1
Median 5Y
1.3
Industry
2.1
vs History
65
vs Industry
63
Median 3Y
1.5
Median 5Y
1.8
Industry
2.7
Forward
1.4
vs History
61
vs Industry
68
Median 3Y
2.5
Median 5Y
2.9
Industry
5.2
vs History
65
vs Industry
46
Median 3Y
5.2
Median 5Y
6.1
Industry
13.5
Forward
5.6
vs History
55
vs Industry
43
Median 3Y
5.6
Median 5Y
6.7
Industry
16.8
Forward
6.3
vs History
77
vs Industry
44
Median 3Y
7.7
Median 5Y
8.8
Industry
15.2
vs History
79
vs Industry
32
Median 3Y
10.9
Median 5Y
14.3
Industry
19.3
vs History
61
vs Industry
60
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Grand Pharmaceutical Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Grand Pharmaceutical Group Ltd
HKEX:512
16.9B HKD 1.6 7 5.3 6.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.2B USD 18.5 90.3 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
350.6B USD 4 23.9 11.6 15
US
Merck & Co Inc
NYSE:MRK
252B USD 4 20.7 10.5 12.6
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
HK
G
Grand Pharmaceutical Group Ltd
HKEX:512
Average P/E: 29.6
7
35%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
G
Grand Pharmaceutical Group Ltd
HKEX:512
Average EV/EBITDA: 414.2
5.3
22%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.6
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
G
Grand Pharmaceutical Group Ltd
HKEX:512
Average EV/EBIT: 1 810.8
6.1
7%
0.9
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.6
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top